Emma Meade
Emma Meade, VP of Clinical Research, Neuromod Devices
Emma Meade is VP of Clinical Research at Neuromod Devices, an Irish-based medical technology company specialising in bimodal neuromodulation for the treatment of tinnitus. In this role, she is responsible for the strategic oversight and operational execution of the company’s clinical research activities, including the development and management of both in-house studies and external collaborative investigations.
With over a decade of experience in the medical device industry, Emma has focused her career on research and development, bringing a depth of expertise that spans from early-stage academic pilot studies to large-scale, multi-centre clinical trials. Notably, she served as the lead on Neuromod’s pivotal controlled trial and played a critical role in regulatory engagements with the U.S. Food and Drug Administration (FDA), contributing to the successful De Novo classification of the Lenire® device.
She holds a Bachelor’s degree in Biomedical Engineering and an MBA from Trinity College Dublin, as well as an MSc in Innovation and Entrepreneurship from KTH Royal Institute of Technology in Stockholm.
Emma is passionate about advancing the clinical translation of evidence-based medical technologies and has contributed to several peer-reviewed publications in high-impact journals. She has presented her work at numerous academic and professional forums, including MedTech Rising (2022), the Joint Defense Veterans Audiology Conference (JDVAC, 2023), and the Tinnitus Research Initiative (TRI) Conferences (2024, 2025). She has also served as a speaker and panellist for workshops organized by the National Clinical Trials Office (NCTO), including sessions on conducting clinical investigations in Ireland and navigating regulatory pathways, presented as part of International Clinical Trials Day in 2023.